News | November 03, 2021
Sun Pharma Q2FY22 PAT jumps to Rs 2088.73 Cr
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
Gini Health works in the domain of personalised healthcare
Acute therapies continue to report strong growth compared to chronic ones.
Filing marks first protein-based vaccine submitted to MHRA for authorization
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
Key takeaways of recent quarter & conference call highlights
Key takeaways of recent quarter & conference call highlights
Subscribe To Our Newsletter & Stay Updated
